Blog
Expanded Opiates Panel: What It Detects and How to Read It
An expanded opiates panel is a urine (or oral fluid) screen that looks beyond the classic opiates, codeine, morphine and heroin’s marker 6-AM, to also include semi-synthetic opioids such as hydrocodone, hydromorphone, oxycodone and oxymorphone. It is a presumptive screen. A positive needs lab confirmation before anyone acts on it, and a negative does not rule out every opioid. This guide explains what is on the panel, the cutoffs that matter, how long drugs stay detectable, and how to choose a format for your program.
TL;DR
- “Expanded” means the panel adds hydrocodone, hydromorphone, oxycodone and oxymorphone to the traditional codeine, morphine and 6-AM markers.
- Federal and DOT panels adopted this expansion in 2017 and 2018, with a 300 ng/mL initial cutoff for the hydrocodone/hydromorphone pair and 100 ng/mL for oxycodone/oxymorphone.
- Most opioids are detectable in urine for roughly two to four days, but hydration, dose, metabolism and urine pH all move that window.
- Immunoassay screens are presumptive. GC/MS or LC-MS/MS confirmation identifies the exact drug.
- Fentanyl and many other synthetic opioids need their own test line, because a standard opiate screen does not detect them.
Table of Contents
- What “expanded opiates” means on a drug test
- Which drugs and metabolites an expanded panel may detect
- Cutoffs: the numbers behind a positive
- Oxycodone versus hydrocodone: what a screen can and cannot separate
- Why someone may test positive, including on a prescription
- How long opioids stay detectable in urine
- Presumptive results, validity checks and confirmation
- Choosing a format: cup, dip card, strip or oral swab
- Our perspective
- Shop expanded opiate screening supplies
- FAQ
- Sources
What “expanded opiates” means on a drug test
A traditional opiate screen is built around morphine. The antibody on the test reacts well to morphine and codeine, and to heroin, which the body converts to morphine. It reacts weakly, or not at all, to semi-synthetic opioids like oxycodone. That gap is why a person taking prescribed oxycodone could pass a basic 300 ng/mL opiate screen.
An expanded opiates panel closes that gap. Depending on the product, it may be a single line that responds to a wider group, or separate lines for oxycodone and for hydrocodone. This is why panel contents vary from one test to another: the name “expanded opiates” describes an intent, not a fixed list. Always read the package insert for the exact analytes and cutoffs.
The federal workplace world made this the norm. Effective January 1, 2018, the U.S. Department of Transportation renamed its “Opiates” category “Opioids” and added testing for hydrocodone, hydromorphone, oxycodone and oxymorphone alongside codeine, morphine and 6-AM. Employers outside DOT regulation often follow the same pattern when they choose a panel.
If you want the clinician’s view of why a 300 ng/mL opiate line misses oxycodone, our guide on opiate screens that miss oxycodone walks through a two-tier plan.
Which drugs and metabolites an expanded panel may detect
Here is how the common analytes group together, and what each one tells you.
| Analyte | What it indicates | Typical note |
|---|---|---|
| Codeine | Codeine itself, or a prescription cough or pain product | Codeine is metabolized to morphine |
| Morphine | Morphine, codeine or heroin | Cannot tell the source on a screen |
| 6-AM (6-acetylmorphine) | Heroin | A marker specific to heroin, short window |
| Hydrocodone / hydromorphone | Hydrocodone, or hydromorphone use | Hydromorphone is also a hydrocodone metabolite |
| Oxycodone / oxymorphone | Oxycodone, or oxymorphone use | Oxymorphone is also an oxycodone metabolite |
Some medical panels go much further. A university hospital’s expanded urine toxicology panel for pain management lists buprenorphine, fentanyl, meperidine, methadone, tapentadol, tramadol and more, with cutoffs across a range of 2 to 300 ng/mL. That is a clinical monitoring tool, a different thing from a workplace or point-of-care screen, but it shows how wide “expanded” can get.
Heroin and the 6-AM marker
Heroin converts to morphine quickly, so a morphine-positive screen alone does not prove heroin use. The marker 6-AM is the specific one. Clinical guidance describes 6-MAM as pathognomonic for heroin use, with a detection window of about 12 to 24 hours. That short window is why a heroin user can screen positive for morphine without a 6-AM result.
Fentanyl is not part of “opiates”
The same clinical FAQ notes that current opiate immunoassays do not detect synthetic opioids such as fentanyl, and confirmation requires GC/MS. If fentanyl matters to your program, you need a dedicated fentanyl line, either as a separate strip or as a position on a multi-panel cup. One laboratory’s expanded screen, for example, uses a 1 ng/mL positive cutoff for fentanyl, a figure far below the opiate cutoffs.
Cutoffs: the numbers behind a positive
A cutoff is the concentration at which a test calls a result positive. Below it, the result reads negative even if some drug is present. Cutoffs differ between initial screens and confirmations.
Under the federal rules cited for DOT testing, the initial cutoff is 300 ng/mL for the hydrocodone/hydromorphone pair and 100 ng/mL for the oxycodone/oxymorphone pair. Confirmation cutoffs are 100 ng/mL for each of hydrocodone, hydromorphone, oxycodone and oxymorphone, and 10 ng/mL for 6-AM.
Other programs set their own numbers. Military drug screening laboratories report confirmation cutoffs of 100 ng/mL for the four semi-synthetics, 10 ng/mL for 6-AM, 4,000 ng/mL for morphine and 2,000 ng/mL for codeine. Clinical monitoring labs can go lower still. One quantitative LC/MS/MS test reports reference ranges below 50 ng/mL for codeine, hydrocodone, hydromorphone, morphine, oxycodone and related metabolites.
The practical lesson: when you compare two panels, compare cutoffs, not just names. Two tests both labeled “expanded opiates” can give different results on the same specimen.

Oxycodone versus hydrocodone: what a screen can and cannot separate
This is the question readers ask most. A urine screen cannot reliably tell whether someone took oxycodone or hydrocodone, and the reason is metabolism.
Guidance from a Washington State medical directors’ group explains that hydrocodone is metabolized in small amounts to hydromorphone, so both may appear in the urine of a hydrocodone user. Likewise, oxycodone is metabolized to oxymorphone. The reverse does not hold: using hydromorphone or oxymorphone directly does not produce a positive for hydrocodone or oxycodone.
So a hydrocodone and hydromorphone result together can be consistent with hydrocodone alone. Hydromorphone by itself points toward hydromorphone use or a different pathway. Codeine adds another layer: it is metabolized to morphine and small quantities of hydrocodone, and a little morphine may convert to hydromorphone, per the VA/DoD provider FAQ.
Separate lines help here. If a program needs to know specifically about hydrocodone or oxycodone, a dedicated test is more informative than a broad group line. We carry a hydrocodone drug test in a 25-strip canister at a 300 ng/mL cutoff and oxycodone drug test strips for exactly this purpose.
Why someone may test positive, including on a prescription
A positive on an opiate screen is not always misuse. Several explanations are common and worth ruling out before drawing conclusions:
- A valid prescription. Codeine, hydrocodone and oxycodone are all prescribed. The test cannot tell prescribed use from other use.
- Metabolic overlap. As above, one drug can produce small amounts of a related one.
- Pharmaceutical impurities. Clinical reference material notes that small amounts of one opiate can show up through minor metabolism routes, and that process impurities, usually 0.1 to 0.5 percent, may also cause unexpected positives. A hospital lab adds that trace hydrocodone can appear alongside roughly 100-fold higher concentrations of oxycodone or hydromorphone because of possible impurity.
- Cross-reactivity on the immunoassay. Screens are antibody-based and can react to related compounds. That is the reason confirmation exists.
If you are the person tested and you take a prescribed opioid, tell the medical review officer or your prescriber, who can interpret the result against your medication list.
How long opioids stay detectable in urine
Detection windows are estimates, not guarantees. A clinical interpretation guide lists average urine detection times of 48 hours for codeine and heroin (detected as morphine), 48 to 72 hours for morphine, two to four days for hydromorphone and oxycodone, and three days for methadone.
The same guide stresses that the window depends on hydration, dose, metabolism (including CYP450 2D6 genetic differences), body mass, urine pH, how long the person has used the drug, and the drug’s own pharmacokinetics. A hospital diagnostics lab gives a similar general interval: two to three days after last ingestion, with a hydrocodone, hydromorphone or oxycodone result above 100 ng/mL indicating exposure within two to three days before collection.
For more on timelines across substances, see our pages on drug detection windows and what they mean and substance detection windows.
A negative result for a drug someone is supposed to be taking needs context. The interpretation guide says the whole clinical picture must be considered: the patient may not be taking the drug, may be on a lower dose, or may be taking it correctly but below the cutoff because of one of those factors.
Presumptive results, validity checks and confirmation
A point-of-care expanded opiates result is presumptive. It tells you the specimen reacted above the cutoff, not which compound caused it.
Specimen validity
Before trusting any result, check that the specimen is genuine. Under the DOT rules, a urine specimen is dilute when creatinine is at least 2 mg/dL but under 20 mg/dL and specific gravity is above 1.0010 but below 1.0030. It is substituted when creatinine is below 2 mg/dL and specific gravity is at or below 1.0010 or at or above 1.0200 on both initial and confirmatory tests. Manufacturers’ validity guidance adds that a confirmed pH from 3.0 up to 4.5, or from 9.0 up to 11.0, is reported as abnormal pH. The same guide notes that a drug-positive result with a validity flag is still a valid result, while a negative with a flag is cause for concern.
Our cups with adulterant lines let you check validity at the time of collection. Ask our team about the right configuration for your program.
When to send for confirmation
When a screen is positive, laboratory confirmation by GC/MS or LC-MS/MS identifies the exact drug and measures its concentration. One reference lab states that when a specimen screens positive, confirmation and quantitation by GC/MS or LC-MS/MS is added at additional charge. A university lab notes that confirmatory testing is available if ordered within two weeks of collection, so keep the specimen and paperwork organized.

Confirmation also does the work that screens cannot: it can rule out false positives from cross-reactivity, catch false negatives from poor cross-reactivity, use lower thresholds, and identify additional drugs, as clinical reference guidance explains. Medical-purposes-only lab tests are not valid for forensic use, so if a result might carry legal or employment consequences, the collection must follow the right chain of custody from the start.
Choosing a format: cup, dip card, strip or oral swab
The panel is one decision; the device is another.
- Test cups are the common choice for workplaces, clinics and treatment programs. The specimen is collected and tested in one container, and many cups include adulterant lines. Our 12 panel cup and 13 panel cup with fentanyl are two examples.
- Dip cards suit labs and clinics that collect into their own specimen cups. See our 10 panel dip card and our comparison of cups versus dip cards.
- Single-drug strips are for targeted questions, such as hydrocodone or oxycodone alone, or for adding one line to a program you already run.
- Oral swabs test saliva and are useful when observed collection is easier than a urine collection. Browse the 9 panel oral swab for one option.
If you are building a program around pain management, our guide on baseline testing before opioids covers when and how clinicians screen. Programs that dispense or monitor opioids may also want naloxone on hand, and a free Narcan program at a treatment center shows how some providers approach overdose readiness.
Our perspective
Most of the confusion we hear from customers comes from one word: “opiates.” People assume it covers every opioid. It does not, and a 300 ng/mL morphine-based screen can walk right past oxycodone.
Our advice is to decide what you need to know first. If you run a clinic or treatment program, choose a panel with separate oxycodone and hydrocodone lines, and add a fentanyl line, since fentanyl sits outside the opiate group. If you are an employer, match the panel to the policy you wrote, then make sure your collection process includes validity checks.
We are a family business, and we stock a wide range of cups, dip cards, strips and oral swabs, with CLIA waived and FDA-approved options, so you can match the device to the question instead of the other way around. And when a result is presumptive, send it for confirmation. That is how screening is meant to work.
Justin
Shop expanded opiate screening supplies
We stock multi-panel cups, dip cards, single-drug strips and oral swabs, with bulk discounts and custom quotes for labs, clinics, treatment centers and employers. Our site shows the panel contents on each product page, so you can check the analytes before you order.

Browse the full range in our drug test shop, or start with a multi-drug option such as the 15 panel cup with adulterant lines.
FAQ
Does an expanded opiates panel detect fentanyl?
Not by itself. Standard opiate immunoassays do not detect synthetic opioids like fentanyl, which has its own test line and its own, much lower, cutoff. If fentanyl is a concern, choose a panel or strip that lists it.
Can a urine test tell oxycodone from hydrocodone?
Only partly. Hydrocodone can produce hydromorphone and oxycodone can produce oxymorphone, so related results often appear together. Confirmation by GC/MS or LC-MS/MS identifies which drug and metabolites are present and at what levels.
How long will opioids show in urine?
Usually about two to four days after last use for most common opioids, shorter for heroin’s 6-AM marker at 12 to 24 hours. Hydration, dose, metabolism, body mass and urine pH can all shift the window.
Why did I test positive for opiates on a prescription?
Prescribed codeine, hydrocodone or oxycodone will produce a positive, and metabolic overlap or trace impurities can add related results. Share your medication list with the medical review officer or your prescriber so the result is read in context.
Sources
- DOT 5 Panel Notice
- Federal cutoffs for DOT testing
- Navy drug laboratory questions and answers
- VA/DoD provider FAQ on urine drug screens
- University of Iowa expanded urine toxicology panel
- Opiates expanded, quantitative, urine test directory
- Interpreting urine drug testing results
- Opiates urine quantitative testing
- Definitive testing: interpreting unexpected results
- Interpretation of opiate urine drug screens
- 49 CFR 40.86 specimen validity
- Specimen validity testing guide
- Drug panel, expanded screen with reflex to quantitation